Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker

Alaggio, 2022, The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms, Leukemia, 36, 1720, 10.1038/s41375-022-01620-2 Pienkowska-Grela, 2011, Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement, Med Oncol, 28, 1589, 10.1007/s12032-010-9614-0 Salaverria, 2014, A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma, Blood, 123, 1187, 10.1182/blood-2013-06-507996 Swerdlow, 2017 Campo, 2022, The international consensus classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee, Blood, 140, 1229, 10.1182/blood.2022015851 Rymkiewicz, 2018, A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration, Mod Pathol, 31, 732, 10.1038/modpathol.2017.186 Wagener, 2019, The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma, Blood, 133, 962, 10.1182/blood-2018-07-864025 Gonzalez-Farre, 2019, Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma, Haematologica, 104, 1822, 10.3324/haematol.2018.207928 Hummel, 2006, A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling, N Engl J Med, 354, 2419, 10.1056/NEJMoa055351 Wagener, 2020, Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma, Haematologica, 105, e202, 10.3324/haematol.2018.208140 Woroniecka, 2022, Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature, PloS One, 17, 10.1371/journal.pone.0263980 King, 2019, False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms, Haematologica, 104, e248, 10.3324/haematol.2018.207290 Dunleavy, 2018, Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective, Blood, 132, 369, 10.1182/blood-2018-02-778480 Horn, 2021, A Diagnostic approach to the identification of Burkitt-like lymphoma with 11q aberration in aggressive B-cell lymphomas, Am J Surg Pathol, 45, 356, 10.1097/PAS.0000000000001613 Au-Yeung, 2020, Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group, Br J Haematol, 190, 753, 10.1111/bjh.16578 Tyanova, 2016, The MaxQuant computational platform for mass spectrometry-based shotgun proteomics, Nat Protoc, 11, 2301, 10.1038/nprot.2016.136 Tyanova, 2016, The Perseus computational platform for comprehensive analysis of (prote)omics data, Nat Methods, 13, 731, 10.1038/nmeth.3901 Wing, 2022, Transcriptome and unique cytokine microenvironment of Castleman disease, Mod Pathol, 35, 451, 10.1038/s41379-021-00950-3 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 550, 10.1186/s13059-014-0550-8 Ge, 2020, ShinyGO: a graphical gene-set enrichment tool for animals and plants, Bioinformatics, 36, 2628, 10.1093/bioinformatics/btz931 Richter, 2012, Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing, Nat Genet, 44, 1316, 10.1038/ng.2469 Schmitz, 2012, Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics, Nature, 490, 116, 10.1038/nature11378 Love, 2012, The genetic landscape of mutations in Burkitt lymphoma, Nat Genet, 44, 1321, 10.1038/ng.2468 Loeffler-Wirth, 2019, A modular transcriptome map of mature B cell lymphomas, Genome Med, 11, 27, 10.1186/s13073-019-0637-7 Evrard, 2019, Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements, Haematologica, 104, e154, 10.3324/haematol.2018.198572 Karube, 2018, Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets, Leukemia, 32, 675, 10.1038/leu.2017.251 Loeffler-Wirth, 2022, Classifying germinal center derived lymphomas-navigate a complex transcriptional landscape, Cancers (Basel), 14, 3434, 10.3390/cancers14143434 Meerabux, 1996, A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas, Cancer Res, 56, 448 Tandon, 2011, Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas, Mod Pathol, 24, 1433, 10.1038/modpathol.2011.103 Walther, 2013, Aberrant lymphocyte enhancer–binding factor 1 expression is characteristic for sporadic Burkitt’s lymphoma, Am J Pathol, 182, 1092, 10.1016/j.ajpath.2012.12.013 Guo, 2015, Characterization of LEF1 high expression and novel mutations in adult acute lymphoblastic leukemia, PloS ONE, 10, 10.1371/journal.pone.0125429 Kühnl, 2011, Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia, Blood, 118, 6362, 10.1182/blood-2011-04-350850 Gebauer, 2021, Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma, Blood Adv, 5, 5220, 10.1182/bloodadvances.2021004635 Havelange, 2016, The peculiar 11q-gain/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma, Cancer Genet, 209, 117, 10.1016/j.cancergen.2015.12.005 Grygalewicz, 2017, The 11q-gain/loss aberration occurs recurrently in MYC-negative Burkitt-like lymphoma with 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS, Am J Clin Pathol, 149, 17, 10.1093/ajcp/aqx139